H2020Individual fellowship2017–2019

BaskAtax · Modulation of Basket cell microcircuits in cerebellar cortex paroxysmal ataxia disorders

Horizon 2020 — Marie Skłodowska-Curie Actions

Duration
2017-10-01 → 2019-09-30
EU contribution
€195,455
Participants
1
Scheme
MSCA-IF-EF-ST

Lines connect the coordinator with its partners.

Results in brief

Modulation of Basket cell microcircuits in cerebellar cortex paroxysmal ataxia disorders

Episodic neurological disorders such as migraine and epilepsy are common, yet in most cases our understanding of their origins and causes remains surprisingly basic. This in turn has hampered the development of targeted therapy for the treatment or relief of symptoms. Typically these disorders have a complex genetic pattern, nevertheless a small subgroup have a simple monogenetic origin. These rare monogenetic episodic disorders can individually affect many genes, however there is a bias towards genes linked to neurotransmission and particularly the function of the synapse the point of communication between neurons in the brain. We have studied a rare congenital neurological disorder called Episodic Ataxia Type 1 (EA1) caused by a dominant negative mutation in the Kcna1 potassium channel. Individuals with EA1 suffer from muscle twitches (myokymia) and paroxysmal events lasting from minutes to hours, characterized by loss of coordinated movement (ataxia). The cerebellum, a brain region often affected in ataxia is enriched with synaptic Kcna1 potassium channels. Consequently it is thought that EA1 mutation in Kcna1 has a pathological role in cerebellar synaptic neurotransmission. In this project it has been our objective to understand the effect of Kcna1 mutation on the function of cerebellum and to investigate potential new treatments. These experiments are not only important to individuals living with EA1, but given the crossover with other synaptic disorders has the potential to identify communalities that can be applied to the class of episodic neurological disorders as a whole. To address these objectives we have recorded the function of the cerebellum in a mouse model of EA1. Contrary to expectations we discovered that the baseline function of the cerebellum was not affected in EA1. This was supported by behavioural assay showing that motor function was retained in these mice. We interpret this to indicate that robust neuronal mechanisms function to normalize cerebellar function in EA1. However, in contrast when we challenged EA1 mice with stimulants aping a paroxysmal event differences became apparent. Using a new behavioural paradigm, we also made the unexpected discovery that male and female EA1 mice are differentially affected. Our experiments suggest that adaptation has an important role in protecting the brain in episodic neurological disorders and that how males and females respond to paroxysmal attack triggers is not necessarily the same.

Data: CORDIS, © European Union

Project objective

The episodic ataxias are a group of hereditary conditions with recurring paroxysms of cerebellar dysfunction. They are rare; however they share important similarities to other more prevalent paroxysmal disorders such as migraine and epilepsy. The prototypic cerebellar cortex paroxysmal disorder is Episodic ataxia 1 (EA1), which is linked to dominantly inherited missense mutations in the Kv1.1 potassium channel subunit. Work from an animal model harbouring a human EA1 mutation reveals altered synaptic function at basket cell terminals in the cerebellar cortex. However how EA1 mutations affect basket cell regulation of Purkinje cell firing is unclear, possibly due to unforeseen changes in a specialized inhibitory structure called the pinceau. Furthermore the mechanism whereby local synaptic deficits extend to global cerebellar cortex network dysfunction during attacks of incoordination is unknown. This MSC research action aims to understand these processes using a combination of cutting edge in vitro and in vivo techniques. Using advanced electrophysiology techniques, I will assay basket cell pinceau function in mouse models of EA1, then using multi-photon and conventional microscopy I will map local basket cell microcircuits. Finally building on in vitro experiments I will assay candidate small molecule therapies in vivo, both with electrophysiology and with behavioural test of cerebellar coordination. The project allows me to train in state-of-the-art in vitro and in vivo methods while drawing on my extensive background in neuropharmacology, biochemistry electrophysiology. This research action will also advance our understanding of paroxysmal neurological disorders and identify new therapeutic targets.

Original text from CORDIS.

Participants

Links

Data: CORDIS, © European Union